论文部分内容阅读
目的探索国内临床路径的发展历程及研究现状。方法通过文献计量学方法,基于CiteSpace软件,对国内自1998年至2017年临床路径领域的相关科学文献进行分析。结果共有9828篇文献纳入分析。最高发文量为2012年的1419篇,近年来发文量明显减少。作者及单位合作网络稀疏。前十年的研究主要集中在减少住院天数和降低医疗成本上,而近十年的研究主要集中于电子病历系统与临床路径对接和临床路径的管理问题上。结论临床路径的发展陷入瓶颈期,目前研究的焦点主要集中在通过电子病历系统实现临床路径的管理。而以标准化路径的覆盖和智能化出入径的选择,代替以往医护人员通过经验判断,减少人工诊治的误差,可能是未来破解临床路径发展瓶颈的关键。
Objective To explore the development history and current research status of clinical path in China. Methods By means of bibliometrics, CiteSpace software was used to analyze the relevant scientific literature in the field of clinical pathology from 1998 to 2017 in China. A total of 9828 articles were included in the analysis. The maximum number of sentinels is 1419 in 2012, and the number of sent texts has been significantly reduced in recent years. Author and unit cooperation network sparse. The first ten years of research focused on reducing the number of days of hospitalization and reducing medical costs, and nearly a decade of research focused on the management of electronic medical records system and clinical pathway docking and clinical pathway. Conclusion The development of clinical pathways is in a bottleneck. The current research focuses on the management of clinical pathways through electronic medical record system. However, taking the standardized path of coverage and the selection of intelligent pathways instead of past medical personnel’s judgment through experience and reducing errors in manual diagnosis and treatment may be the key to solving the bottleneck of clinical path development in the future.